Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · Real-Time Price · USD
2.746
+0.026 (0.94%)
Nov 21, 2024, 11:51 AM EST - Market open
Poseida Therapeutics Market Cap
Poseida Therapeutics has a market cap or net worth of $267.59 million as of November 21, 2024. Its market cap has increased by 15.14% in one year.
Market Cap
267.59M
Enterprise Value
116.98M
1-Year Change
15.14%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since July 10, 2020, Poseida Therapeutics's market cap has decreased from $948.87M to $267.59M, a decrease of -71.80%. That is a compound annual growth rate of -25.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 265.10M | -17.49% |
| Dec 29, 2023 | 321.30M | -29.47% |
| Dec 30, 2022 | 455.53M | 7.02% |
| Dec 31, 2021 | 425.67M | -37.23% |
| Dec 31, 2020 | 678.17M | -28.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 285.71M |
| Accolade | 281.07M |
| Rezolute | 277.40M |
| AngioDynamics | 274.48M |
| Eton Pharmaceuticals | 273.09M |
| Mersana Therapeutics | 269.30M |
| Atea Pharmaceuticals | 266.91M |
| NeuroPace | 266.84M |